Cue Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,485
Closed -$1.62M 59
2018
Q3
$1.62M Sell
6,485
-130
-2% -$31.6K 0.97% 31
2018
Q2
$1.44M Buy
6,615
+570
+9% +$117K 0.88% 36
2018
Q1
$1.16M Buy
6,045
+305
+5% +$56.3K 0.76% 43
2017
Q4
$898K Buy
5,740
+195
+4% +$30.7K 0.59% 60
2017
Q3
$862K Buy
5,545
+3,090
+126% +$489K 0.6% 58
2017
Q2
$396K Buy
2,455
+245
+11% +$39.8K 0.28% 111
2017
Q1
$342K Buy
+2,210
New +$305K 0.26% 115

Other funds holding IDXX

Cue Advisory Services's IDXX Position: Q4 2018 in Review

Cue Advisory Services sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 6,485 shares — an estimated $1.62M sold.

Cue Advisory Services first reported a position in IDXX in Q1 2017 and held it in 7 quarters. The position peaked at $1.62M in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Cue Advisory Services reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
  • Cue Advisory Services sold 6,485 Idexx Laboratories shares in Q4 2018, an estimated $1.62M.
  • Cue Advisory Services first reported a position in Idexx Laboratories in Q1 2017 and held it in 7 quarters.
  • Cue Advisory Services's Idexx Laboratories position peaked at $1.62M in Q3 2018.
  • 670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.